The Food and Drug Administration will ask a group of outside medical experts next month to evaluate a much-debated experimental drug designed to boost sexual desire in women.
May 7, 2015
0
5
Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. Joel Lexchin in the School of Health Policy and Management.
May 7, 2015
0
6
Alexion Pharmaceuticals will pay a huge premium to buy Synageva BioPharma in an $8.4-billion deal for a rare disease treatment maker that lost nearly $60 million in the first quarter and has no products on the market.
May 6, 2015
0
4
The health insurer Aetna is ending most coverage of hysterectomies performed with a once-popular device that has drawn warnings from federal regulators over a risk for spreading cancer.
May 5, 2015
0
30
To fight infections, hospital workers can hit the hand sanitizer a hundred times or more a day. Now, the government wants more study of whether that is safe and how well it actually fights the spread of germs.
Apr 30, 2015
0
3
This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are approved for a variety of cancers, as forecast recently by Drew Pardoll, MD, PhD, in a blog post. There is huge ...
Apr 30, 2015
0
5
The Food and Drug Administration said Wednesday it approved an injection designed to melt away double-chin fat.
Apr 29, 2015
0
20
The Food and Drug Administration says Medtronic must stop most sales of its implantable drug pumps after years of uncorrected problems.
Apr 27, 2015
0
4
Chipotle says it has completed phasing out genetically modified ingredients from its food, making it the first national fast-food chain to do so.
Apr 27, 2015
0
4
PepsiCo said Friday it was bowing to customer demand and doing away with the controversial sweetener aspartame in its diet line of cola drinks in the US.
Apr 24, 2015
0
27
